It is a pharma private limited company based in New Delhi, Delhi, India, established in 2019.
2019 | New Delhi, Delhi, India | ActiveGalipea Molecules Private Limited, a active private limited company, was established on 18 June 2019 in New Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24299DL2019PTC351484. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Rameshwar Kumar (Director), Srishti Shaumya (Director). Past directors included Utpal Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No.-44-C-2C Janakpuri P & T Colony, New Delhi, Delhi, 110058.
U24299DL2019PTC351484
351484
18 June 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Galipea Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rameshwar Kumar | Director | 18 Jun 2019 | Current |
| Srishti Shaumya | Director | 18 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Galipea Molecules Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 71.64% decrease. The company also saw a substantial fall in profitability, with a 16519.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2321.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Galipea Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Galipea Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galipea Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galipea Molecules's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Galipea Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Galipea Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Srishti Shaumya was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was completed.
Progress on Rameshwar Kumar was appointed as a Director was appointed as a Director on 18 Jun 2019 & has been associated with this company since 6 years 6 months . was documented.
The activity Galipea Molecules Private Limited was registered on 18 Jun 2019 with Roc Delhi & aged 6 years 6 months as per MCA records. was completed.
The CIN of Galipea Molecules Private Limited is U24299DL2019PTC351484.
Galipea Molecules Private Limited is headquartered at House No.-44-C-2C Janakpuri P & T Colony, New Delhi, Delhi, 110058.
Galipea Molecules Private Limited was incorporated on 18 June 2019.
The current directors of Galipea Molecules Private Limited are
The primary industry of Galipea Molecules Private Limited is Hospital And Medical Care.
Galipea Molecules Private Limited is unlisted.
The authorized capital of Galipea Molecules Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX